1. Home
  2. STTK vs KEQU Comparison

STTK vs KEQU Comparison

Compare STTK & KEQU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$4.76

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

N/A

Current Price

$37.97

Market Cap

106.6M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
STTK
KEQU
Founded
2016
1906
Country
United States
United States
Employees
N/A
1239
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
106.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
STTK
KEQU
Price
$4.76
$37.97
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
626.6K
6.6K
Earning Date
11-06-2025
12-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
3.94
Revenue
$1,000,000.00
$285,515,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$9.44
Revenue Growth
N/A
43.02
52 Week Low
$0.69
$30.33
52 Week High
$4.89
$71.33

Technical Indicators

Market Signals
Indicator
STTK
KEQU
Relative Strength Index (RSI) 75.73 49.44
Support Level $4.09 $37.13
Resistance Level $4.89 $38.50
Average True Range (ATR) 0.34 0.90
MACD 0.07 0.09
Stochastic Oscillator 89.50 47.62

Price Performance

Historical Comparison
STTK
KEQU

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

Share on Social Networks: